Gemma S. P.
- Country
- Spain
- Department
- Radiotherapy oncology service
Research Overview
- Phase 3 Randomized, Double-blind, Placebo-controlled Study of Apalutamide and GnRH Agonist in High-risk Localized or Locally Advanced Prostate Cancer with Primary Radiation Therapy
- Evaluation of Fractionated Stereotactic Radiotherapy Combined with Abiraterone Acetate and Enzalutamide in Oligometastatic Castration-Resistant Prostate Cancer
- Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 Trial
Data & Insights
Has run more than one trial at 12 of 113 partner sites.
Specializations
Advanced Prostate Cancer Management
This investigator specializes in treating high-risk localized and locally advanced prostate cancer, with particular focus on combining radiation therapy with innovative hormonal treatments.
- Primary radiation therapy protocols
- GnRH agonist combination treatments
- Metastasis-free survival optimization
Their work emphasizes the integration of conventional and PSMA-PET imaging for treatment monitoring.
Post-Surgical Therapeutic Approaches
The investigator focuses on developing optimal treatment strategies for post-surgical prostate cancer recurrence, particularly examining the effectiveness of combined therapies.
- Salvage radiotherapy protocols
- Androgen deprivation therapy (ADT)
- Long-term versus short-term therapeutic comparisons
Their research explores the timing and duration of hormone therapy in conjunction with radiation treatments.
Oligometastatic Disease Treatment
The investigator has developed expertise in treating oligometastatic castration-resistant prostate cancer using advanced therapeutic combinations.
- Stereotactic radiotherapy applications
- Second-generation antiandrogen therapy
- Advanced imaging techniques for progression monitoring
Their work incorporates both choline PET/CT and 68Ga-PSMA PET/CT for precise disease monitoring.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.